{"id":5,"date":"2021-06-26T11:12:51","date_gmt":"2021-06-26T11:12:51","guid":{"rendered":"https:\/\/mims.parabolasolution.com\/?page_id=5"},"modified":"2026-02-27T09:14:40","modified_gmt":"2026-02-27T01:14:40","slug":"landing","status":"publish","type":"page","link":"https:\/\/bms.mimsit.net\/dosing\/","title":{"rendered":"Landing"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"5\" class=\"elementor elementor-5\" data-elementor-settings=\"[]\">\n\t\t\t\t\t\t\t<div class=\"elementor-section-wrap\">\n\t\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-17b0e5cb elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"17b0e5cb\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-11159cb\" data-id=\"11159cb\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-d999ef0 elementor-widget elementor-widget-text-editor\" data-id=\"d999ef0\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<style>\/*! elementor - v3.5.5 - 03-02-2022 *\/\n.elementor-widget-text-editor.elementor-drop-cap-view-stacked .elementor-drop-cap{background-color:#818a91;color:#fff}.elementor-widget-text-editor.elementor-drop-cap-view-framed .elementor-drop-cap{color:#818a91;border:3px solid;background-color:transparent}.elementor-widget-text-editor:not(.elementor-drop-cap-view-default) .elementor-drop-cap{margin-top:8px}.elementor-widget-text-editor:not(.elementor-drop-cap-view-default) .elementor-drop-cap-letter{width:1em;height:1em}.elementor-widget-text-editor .elementor-drop-cap{float:left;text-align:center;line-height:1;font-size:50px}.elementor-widget-text-editor .elementor-drop-cap-letter{display:inline-block}<\/style>\t\t\t\t<div class=\"row justify-content-evenly\">\n<div class=\"col-12 col-md-6 col-lg-3 px-5 py-1 p-md-4\">\n<p><a class=\"text-dark text-decoration-none\" href=\"https:\/\/bms.mimsit.net\/dosing\/1l-metastatic-recurrent-nsclc-with-chemo\"><br \/><img decoding=\"async\" class=\"img-fluid px-5 py-3 p-md-4\" src=\"\/dosing\/wp-content\/uploads\/2021\/06\/ball_lung.png\" \/><\/a><\/p>\n<p class=\"h5 text-center font-weight-600\" style=\"margin-top: -15px;\">1L metastatic\/recurrent NSCLC (with chemo)<\/p>\n<p>&nbsp;<\/p>\n<\/div>\n<div class=\"col-12 col-md-6 col-lg-3 px-5 py-1 p-md-4\">\n<p><a class=\"text-dark text-decoration-none\" href=\"https:\/\/bms.mimsit.net\/dosing\/1l-unresectable-malignant-pleural-mesothelioma\"><br \/><img decoding=\"async\" class=\"img-fluid px-5 py-3 p-md-4\" src=\"\/dosing\/wp-content\/uploads\/2021\/06\/ball_lung.png\" \/><\/a><\/p>\n<p class=\"h5 text-center font-weight-600\" style=\"margin-top: -15px;\">1L unresectable malignant pleural mesothelioma<\/p>\n<p>&nbsp;<\/p>\n<\/div>\n<div class=\"col-12 col-md-6 col-lg-3 px-5 py-1 p-md-4\">\n<p><a class=\"text-dark text-decoration-none\" href=\"https:\/\/bms.mimsit.net\/dosing\/1l-advanced-ccrcc\"><br \/><img decoding=\"async\" class=\"img-fluid px-5 py-3 p-md-4\" src=\"\/dosing\/wp-content\/uploads\/2021\/06\/ball_kidney.png\" \/><\/a><\/p>\n<p class=\"h5 text-center font-weight-600\" style=\"margin-top: -15px;\">1L advanced ccRCC<sup>*<\/sup><\/p>\n<p>&nbsp;<\/p>\n<\/div>\n<div class=\"col-12 col-md-6 col-lg-3 px-5 py-1 p-md-4\">\n<p><a class=\"text-dark text-decoration-none\" href=\"https:\/\/bms.mimsit.net\/dosing\/1l-advanced-hcc\"><br \/><img decoding=\"async\" class=\"img-fluid px-5 py-3 p-md-4\" src=\"\/dosing\/wp-content\/uploads\/2021\/06\/ball_liver.png\" \/><\/a><\/p>\n<p class=\"h5 text-center font-weight-600\" style=\"margin-top: -15px;\">1L+ advanced HCC<\/p>\n<p>&nbsp;<\/p>\n<\/div>\n<div class=\"col-12 col-md-6 col-lg-3 px-5 py-1 p-md-4\">\n<p><a class=\"text-dark text-decoration-none\" href=\"https:\/\/bms.mimsit.net\/dosing\/metastatic-unresectable-melanoma\"><br \/><img decoding=\"async\" class=\"img-fluid px-5 py-3 p-md-4\" src=\"\/dosing\/wp-content\/uploads\/2021\/06\/ball_skin.png\" \/><\/a><\/p>\n<p class=\"h5 text-center font-weight-600\" style=\"margin-top: -15px;\">Metastatic\/unresectable melanoma<\/p>\n<p>&nbsp;<\/p>\n<\/div>\n<div class=\"col-12 col-md-6 col-lg-3 px-5 py-1 p-md-4\">\n<p><a class=\"text-dark text-decoration-none\" href=\"https:\/\/bms.mimsit.net\/dosing\/1l-msi-h-d-mmr-metastatic-recurrent-crc\"><br \/><img decoding=\"async\" class=\"img-fluid px-5 py-3 p-md-4\" src=\"\/dosing\/wp-content\/uploads\/2021\/06\/ball_colon.png\" \/><\/a><\/p>\n<p class=\"h5 text-center font-weight-600\" style=\"margin-top: -15px;\">1L+ MSI-H\/d-MMR metastatic\/recurrent CRC<\/p>\n<p>&nbsp;<\/p>\n<\/div>\n<div class=\"col-12 col-md-6 col-lg-3 px-5 py-1 p-md-4\">\n<p><a class=\"text-dark text-decoration-none\" href=\"https:\/\/bms.mimsit.net\/dosing\/1l-unresectable-advanced-recurrent-metastatic-escc\/\"><br \/><img decoding=\"async\" class=\"img-fluid px-5 py-3 p-md-4\" src=\"\/dosing\/wp-content\/uploads\/2023\/10\/ball_eso.png\" \/><\/a><\/p>\n<p class=\"h5 text-center font-weight-600\" style=\"margin-top: -15px;\">1L unresectable advanced\/recurrent\/ metastatic ESCC<\/p>\n<\/div>\n<\/div>\n<p><!-- \/wp:verse --><\/p>\n<p><!-- wp:paragraph --><\/p>\n<p><!-- \/wp:paragraph --><\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-67a3284 elementor-widget elementor-widget-text-editor\" data-id=\"67a3284\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<p><sup>#<\/sup>This guide is for scientific education purposes only in response to your enquires\/request. For further enquiries, please contact your local BMS Medical Science Liaison or contact BMS Medical Information Department at\u00a0<a href=\"mailto:medinfo.hongkong@bms.com\">medinfo.hongkong@bms.com<\/a>.<\/p>\n<p><sup>*<\/sup>Nivolumab in combination with ipilimumab is only approved for 1L ccRCC patients with an intermediate or poor risk profile.<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-73c1f75 elementor-widget elementor-widget-text-editor\" data-id=\"73c1f75\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<p>1L, first-line; 2L+, second-line or later; ccRCC, clear cell renal cell carcinoma; CRC, colorectal cancer; d-MMR, mismatch repair deficient; ESCC, esophageal squamous cell carcinoma; FDA, US Food and Drug Administration; HCC, hepatocellular carcinoma; MSI-H, high microsatellite instability; NSCLC, non-small cell lung cancer.<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>1L metastatic\/recurrent NSCLC (with chemo) &nbsp; 1L unresectable malignant pleural mesothelioma &nbsp; 1L advanced ccRCC* &nbsp; 1L+ advanced HCC &nbsp; Metastatic\/unresectable melanoma &nbsp; 1L+ MSI-H\/d-MMR metastatic\/recurrent CRC &nbsp; 1L unresectable advanced\/recurrent\/ metastatic ESCC #This guide is for scientific education purposes only in response to your enquires\/request. For further enquiries, please contact your local BMS Medical [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-5","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/bms.mimsit.net\/dosing\/wp-json\/wp\/v2\/pages\/5","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bms.mimsit.net\/dosing\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/bms.mimsit.net\/dosing\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/bms.mimsit.net\/dosing\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bms.mimsit.net\/dosing\/wp-json\/wp\/v2\/comments?post=5"}],"version-history":[{"count":144,"href":"https:\/\/bms.mimsit.net\/dosing\/wp-json\/wp\/v2\/pages\/5\/revisions"}],"predecessor-version":[{"id":1570,"href":"https:\/\/bms.mimsit.net\/dosing\/wp-json\/wp\/v2\/pages\/5\/revisions\/1570"}],"wp:attachment":[{"href":"https:\/\/bms.mimsit.net\/dosing\/wp-json\/wp\/v2\/media?parent=5"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}